Navigation Links
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
Date:5/30/2008

IIIA NSCLC in the large MAGRIT trial. The gene profiling data presented at ASCO will be further validated during the ongoing NSCLC MAGRIT Phase III trial.

"This is an exciting time to be amongst those at the forefront of cancer immunotherapy research," said Dr. Vincent Brichard, Vice-President, Head of Cancer Immunotherapeutics at GSK Biologicals. "These data presented today and the launch of the large MAGRIT trial are indicative of GSK's ongoing commitment to researching new ways of treating cancer and focus on developing the right medicine tailored to identify the patients most likely to benefit from it. We are keenly anticipating the results of the Phase III trial and what it may mean for the future of cancer treatment."

About ASCIs and MAGE-A3 ASCI

GSK's ASCIs represent a novel class of medicines designed to train the immune system to recognize and eliminate cancer cells in a highly specific manner. These novel cancer immunotherapeutics combine tumor antigens, delivered as purified recombinant proteins, and GSK's proprietary Adjuvant Systems which are specific combinations of immunostimulating compounds selected to increase the anti-tumor immune response. ASCIs will be investigated to support their use to reduce the risk of tumor recurrence following surgery, or to impact tumor growth in an early metastatic setting.

The highly specific mode of action of GSK's ASCIs may not only avoid harming the normal tissue but also aid in selecting patients eligible for the treatment, depending on the expression of the tumor antigens.

MAGE-A3 is a tumor-specific antigen that is expressed in a large variety of cancers, including Melanoma, Non-Small Cell Lung Cancer, Head and Neck Cancer, Bladder Cancer, with no expression in normal cells. Expression of the MAGE-A3 gene has been observed in testicular cells but without antigen presentation capabilities.

MAGE-A3 protein has been in-licensed by GSK from the Ludwig Institute for Cancer Re
'/>"/>

SOURCE GlaxoSmithKline (GSK)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Presentation of Data on Progens Cancer Epigenetic Targets Platform
2. Genmab Announces Updates on Phase III Cancer Studies
3. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
4. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
5. BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer
6. Prostate Cancer Treatment Offers Results Without Side Effects
7. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
8. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
9. Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
10. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
11. Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq: ... meeting of stockholders held today, the Company,s stockholders adopted ... and among the Company, Healthy Harmony Holdings, L.P. ("Parent"), ... an affiliate of TPG, Shanghai Fosun Pharmaceutical (Group) Co., ... CEO of the Company. The Merger Agreement ...
(Date:9/16/2014)... NEW YORK , Sept. 16, 2014  This report ... and Units, The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... America , and Rest of World. Annual estimates and ... a seven-year historic analysis is provided for these markets. Market ...
(Date:9/16/2014)... , Sept. 16, 2014 This report analyzes the ... following Product Segments: Devices, and Medication. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology:Chindex Stockholders Approve Merger 2Chindex Stockholders Approve Merger 3Global Digital Radiography Industry 2Global Digital Radiography Industry 3Global Digital Radiography Industry 4Global Digital Radiography Industry 5Global Digital Radiography Industry 6Global Digital Radiography Industry 7Global Digital Radiography Industry 8Global Digital Radiography Industry 9Global Digital Radiography Industry 10Global Digital Radiography Industry 11Global Digital Radiography Industry 12Global Digital Radiography Industry 13Global Digital Radiography Industry 14Global Digital Radiography Industry 15Global Digital Radiography Industry 16Global Digital Radiography Industry 17Global Digital Radiography Industry 18Global Digital Radiography Industry 19Global Digital Radiography Industry 20Global Digital Radiography Industry 21Global Digital Radiography Industry 22Global Foot Care Products Industry 2Global Foot Care Products Industry 3Global Foot Care Products Industry 4Global Foot Care Products Industry 5Global Foot Care Products Industry 6Global Foot Care Products Industry 7Global Foot Care Products Industry 8Global Foot Care Products Industry 9Global Foot Care Products Industry 10Global Foot Care Products Industry 11Global Foot Care Products Industry 12Global Foot Care Products Industry 13
... Calif., Aug. 31, 2011 The healthcare professionals at ... of orthopaedic surgeries on children each year, are using ... (NASDAQ: MASI ) to noninvasively monitor patient ... needles, the innovative technology instantly lets the healthcare team ...
... AVIV, Israel, August 31, 2011 Elbit Imaging ... results for the second quarter of 2011. Consolidated ... amounted to NIS 241 million (US$ 71 million) compared to NIS ... The decrease is mainly attributable to: (i) we reported non-recurring gain ...
Cached Medicine Technology:Shriners Hospitals for Children® - Honolulu: First in Hawaii to Implement Masimo Noninvasive Hemoglobin Monitoring Technology 2Shriners Hospitals for Children® - Honolulu: First in Hawaii to Implement Masimo Noninvasive Hemoglobin Monitoring Technology 3Shriners Hospitals for Children® - Honolulu: First in Hawaii to Implement Masimo Noninvasive Hemoglobin Monitoring Technology 4Shriners Hospitals for Children® - Honolulu: First in Hawaii to Implement Masimo Noninvasive Hemoglobin Monitoring Technology 5Elbit Imaging Ltd. Announces Second Quarter Results for 2011 2Elbit Imaging Ltd. Announces Second Quarter Results for 2011 3Elbit Imaging Ltd. Announces Second Quarter Results for 2011 4Elbit Imaging Ltd. Announces Second Quarter Results for 2011 5Elbit Imaging Ltd. Announces Second Quarter Results for 2011 6Elbit Imaging Ltd. Announces Second Quarter Results for 2011 7Elbit Imaging Ltd. Announces Second Quarter Results for 2011 8Elbit Imaging Ltd. Announces Second Quarter Results for 2011 9Elbit Imaging Ltd. Announces Second Quarter Results for 2011 10
(Date:9/17/2014)... (PRWEB) September 17, 2014 Holon ... (DHCHD) has implemented its CollaborNet™ Health Information ... of patients’ health information between Coon Memorial Hospital, ... and physicians in the community. , Coon ... to enable electronic referrals by physicians to the ...
(Date:9/17/2014)... NY (PRWEB) September 17, 2014 ... sports, concussion prevention is top of mind for ... five facts to remember about concussions and an ... developed for kids, parents, coaches and teachers to ... , "As a pediatric orthopedic surgeon, ...
(Date:9/17/2014)... 2014 On October 1-2, Voom will ... lineup at Techmanity, a celebration of the intersection of ... tech events,” Techmanity will host the best and brightest ... the ranks of Cisco, PayPal, Samsung, Silicon Valley Bank, ... Technology Conference. , Voom was created to address the ...
(Date:9/17/2014)... 1st-Dress.com, one of the most distinguished dress companies, ... dresses recently. All the fresh items provided in ... they are offered at deeply discounted rates at the ... firm is striving to provide a nice shopping experience ... compromises on style, quality and customer service. Currently, similar ...
(Date:9/16/2014)... September 17, 2014 Dog Food Secrets ... owners the true poisonous ingredients in most commercial dog food ... has caught the attention of Shane Michaels, prompting an investigative ... as much of a family member as any other human ... dies earlier than it should due to poor diet” reports ...
Breaking Medicine News(10 mins):Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 2Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 3Health News:Video Helps Kids and Adults Talk About Concussion Recognition and Treatment 2Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:2014 Long Bridesmaid Dresses Available Online At 1st-Dress.com 2Health News:Dog Food Secrets: Review Exposes Andrew Lewis’ Guide to Happier, Healthier Dogs with Homemade Dog Food 2
... ... In 20 Minutes Twice A Week , ... Bunker Hill Village, Houston (Vocus) August 17, 2009 -- SuperSlow® Zone of ... SuperSlow® Zone at 9738 Katy Freeway, Suite 200 provides a one-on-one efficient, effective workout ...
... HOUSTON, Aug. 17 After nearly four years of joint ... and NASA / Johnson Space Center (JSC), a senior NASA medical officer ... and tested in space by the astronauts of mission STS-125 of May ... now in use and testing aboard the International Space Station. , ...
... , , , , ... Hospital scientists lead survey of genome that identifies new genes ... MEMPHIS, Tenn., Aug. 16 Scientists at St. Jude Children,s Research ... percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may ...
... online interventions now await , SUNDAY, Aug. 16 (HealthDay ... games and gossip, news and entertainment, essential information and ... as well. , A number of successful online medical ... quit smoking, lower their blood pressure and deal with ...
... Escape ... to freedom from addiction to drugs and alcohol. This service is provided in ... the convenience of the client,s personal/professional schedule. , ... Monticello, Minnesota (PRWEB) August 15, 2009 -- Jeanie Cooke, ...
... KUNMING, China, Aug. 14 /PRNewswire-Asia-FirstCall/ -- ... Shenghuo" or,the "Company"), which is engaged in the research, ... products,in the People,s Republic of China ("PRC"), today reported ... 2009. , , Second Quarter 2009 ...
Cached Medicine News:Health News:SuperSlow Zone Opens in Bunker Hill Village 2Health News:Astronauts Test Use of Nutritional Supplements in Space 2Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 2Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 3Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 4Health News:Web Is Becoming One-Stop Shopping for Health Help 2Health News:Web Is Becoming One-Stop Shopping for Health Help 3Health News:Licensed Drug and Alcohol Counselor Offers Minimal Cost On-Line Guidance to Freedom from Addiction 2Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 2Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 3Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 4Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 5Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 6Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 7Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 8Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 9Health News:China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009 10
Welch Allyn quality in a convenient pocket size. The PocketScope fits into your pocket! Easy to use, lightweight, and perfect for general and specialist use. Take your PocketScope with you everywhere...
... processing system assures a perfect fit of ... the convenience of complete automatic operation. The ... advanced processing unit and large LCD display. ... feature (ALE-3700 PC) or a polishing feature ...
... The new ULTIMA SG and ULTIMA ... todays progressive optical environments. These new products ... a host of innovative new features at ... features all-material edging, a large color LCD ...
... all the features of the FR-20 Frame Reader ... you no longer need to connect the frame ... is capable of receiving data via a cable ... you to streamline your edging operations. It stores ...
Medicine Products: